Vonvendi^TM (vonicog alfa) recombinant von willebrand factor – von willebrand disease - Update list - January 2020

To meet the needs of the Québec Ministry of Health and Social Services (MSSS), INESSS has developed an evaluation process for blood products with a view to their addition or refusal of their addition to Québec’s list of approved blood products (Liste des produits du système du sang du Québec).

This guidance presents the recommendation of INESSS to not add Vonvendi^TM (vonicog alfa) to the Liste des produits du système du sang du Québec. A higher level of evidence is required to support its therapeutic value.